XML 42 R24.htm IDEA: XBRL DOCUMENT v3.21.2
SEGMENT INFORMATION
 12 Months Ended
Oct. 01, 2021
Segment Reporting [Abstract]  
SEGMENT INFORMATION SEGMENT INFORMATION
    The Company has two reportable operating segments: Medical and Industrial, which aligns with how its Chief Executive Officer ("CEO"), who is the Company's Chief Operating Decision Maker (“CODM”), reviews the Company’s performance. The segments align the Company’s products and service offerings with customer use in medical and industrial markets and are consistent with how the Company’s CEO, who is also its CODM, evaluates the business for the allocation of resources. The CODM allocates resources to and evaluates the financial performance of each operating segment primarily based on revenues and gross profit. The operating and reportable segment structure provides alignment between business strategies and operating results.
Description of Segments
    The Medical segment designs, manufactures, sells and services X-ray imaging components, including X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, heat exchangers, ionization chambers and buckys (a component of X-ray units that holds X-ray film cassettes). These components are used in a range of medical imaging applications including CT, mammography, oncology, cardiac, surgery, dental, and other diagnostic radiography uses.
    The Industrial segment designs, develops, manufactures, sells and services X-ray imaging products for use in a number of markets, including security applications for cargo screening at ports and borders and baggage screening at airports, and nondestructive testing and inspection applications used in a number of other markets. The Company's Industrial products include Linatron® X-ray linear accelerators, X-ray tubes, digital detectors and high voltage connectors. In addition, the Company licenses proprietary image-processing and detection software designed to work with other Varex products to provide packaged sub-assembly solutions to Industrial customers.
    Accordingly, the following information is provided for purposes of achieving an understanding of operations, but it may not be indicative of the financial results of the reported segments were they independent organizations. In addition, comparisons of the Company’s operations to similar operations of other companies may not be meaningful.
    Information related to the Company’s segments is as follows:
Fiscal Year
(In millions)
202120202019
Revenues
Medical
$643.8 $584.5 $596.8 
Industrial
174.3 153.8 183.8 
Total revenues
818.1 738.3 780.6 
Gross profit
Medical
203.2 136.4 188.9 
Industrial
68.3 53.8 67.8 
Total gross profit
271.5 190.2 256.7 
Total operating expenses
197.4 223.9 211.0 
Interest and other expense, net(45.5)(38.9)(24.2)
Income (loss) before taxes28.6 (72.6)21.5 
Income tax expense (benefit)10.7 (15.2)5.7 
Net income (loss)17.9 (57.4)15.8 
Less: Net income attributable to noncontrolling interests0.5 0.5 0.3 
Net income (loss) attributable to Varex$17.4 $(57.9)$15.5 

    The Company does not disclose total assets by segment as this information is not provided to the CODM.

Geographic Information
RevenuesLong-Lived Assets
Fiscal YearsFiscal Years
(In millions)20212020201920212020
Americas
$268.5 $255.0 $282.6 $105.4 $115.9 
EMEA
276.3 231.5 269.0 23.9 21.5 
APAC
273.3 251.8 229.0 10.9 7.8 
Total company
$818.1 $738.3 $780.6 $140.2 $145.2 

    Revenue in the United States of America was $262.3 million, $249.8 million and $275.3 million in fiscal years 2021, 2020 and 2019, respectively.
    The Company operates various manufacturing and marketing operations outside the United States. Americas includes North and South America. EMEA includes Europe, Russia, the Middle East, India and Africa. APAC includes Asia and Australia. Revenues by region are based on the known final destination of products sold.